L. Perseu

Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus

Beta-thalassemia

The promise and challenge of therapeutic genome editing

Lineage-Specific Changes in Biomarkers in Great Apes and Humans

The β-Thalassemias

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, β^S‐globin gene haplotype, co‐inherited α‐thalassemia trait and Hb F on steady‐state serum bilirubin levels in sickle cell anemia

Phototherapy for Neonatal Jaundice

6 β-Thalassaemia

The muscular dystrophies

Phenotype—genotype relationships in monogenic disease: lessons from the thalassaemias

Sickle-cell disease

7 Increased HbF in adult life

Cornerstones of CRISPR–Cas in drug discovery and therapy

Neonatal Hyperbilirubinemia

8 Prenatal diagnosis and screening of the haemoglobinopathies

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Racial variability in the UDP-glucuronosyltransferase 1 ( UGT1A1 ) promoter: A balanced polymorphism for regulation of bilirubin metabolism?

Bilirubin Genetics for the Nongeneticist: Hereditary Defects of Neonatal Bilirubin Conjugation

Thalassemia minor, the Gilbert mutation, and the risk of gallstones.

Genotype of subjects with borderline hemoglobin A2 levels: Implication for, β‐thalassemia carrier screening

Hyperbilirubinaemia in heterozygous β‐thalassaemia is related to co‐inherited Gilbert's syndrome

Evaluation of an automatic HPLC analyser for thalassemia and haemoglobin variants screening

Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta- thalassemia in a non-beta-thalassemia chromosome [letter]